Somatuline Depot (lanreotide) — Medica
Pheochromocytoma
Initial criteria
- Medication is prescribed by or in consultation with an endocrinologist, oncologist, or neurologist
Reauthorization criteria
- Prescriber continues to be an endocrinologist, oncologist, or neurologist
- Continued need for treatment as determined by clinical assessment
Approval duration
1 year